About Manchester Royal Eye Hospital Charity 


Manchester Royal Eye Hospital is one of the largest teaching hospitals in Europe. Globally acknowledged as a centre of excellence, Manchester Royal Eye Hospital is renowned for its pioneering work in all aspects of ophthalmology, including patient care, surgery and education.

The aim of Manchester Royal Eye Hospital Charity is to support continued excellence in treatment, care and research to enhance the lives of thousands of patients and their families each year. 

The charity helps to provide the hospital with leading state-of-the-art equipment so that the exceptional doctors and nurses can improve diagnosis and treatment and continue to offer patients world-class care. The charity also support s the development of more family-friendly spaces within the hospital, to help patients and their families feel a little more able to relax at what can be a very difficult time for them. In addition to this the charity also helps to support early stage research into better ways to understand and treat eye conditions. 


About Medical Research at the University of Manchester 

The University of Manchester is one of the UK’s leading research universities. The results of the 2008 Research Assessment Exercise, which measures the quality of research conducted in UK universities, places Manchester in the top three, only behind Oxford and Cambridge.  

Our research power combined with our vital NHS partnerships means we are in the best possible position to rapidly translate discoveries for the benefit of patients. We have matched our strengths to areas of exceptional patient need and have identified genetic medicine as a major priority. Through an expanded programme of research we will transform our impact for patients locally, nationally and across the globe.  

The University of Manchester’s history is closely intertwined with the visionary philanthropists who made its existence possible. Philanthropy today continues to play a critical role in accelerating our research so together we can change the future for patients and their families.  


Childhood Genetic Eye Disease:

Supporting The University of Manchester and the Manchester Royal Eye Hospital 

The University of Manchester and Manchester Royal Eye Hospital share the same vision to be a world-leading paediatric centre for genetic diseases to make lives better for children and their families. This requires both outstanding research AND a well-equipped and welcoming clinic.  The University and the Hospital are delighted Michael has chosen to jointly support their work in 2014.

Supporting research at the University of Manchester: 

Currently the reality for families is that inherited eye disease is not cure-able. Professor Black and his colleagues refuse to accept this for the future. Their Manchester vision is to accelerate research to bring improvements to patients and families as quickly as possible.   

Their world class research programme – including improving genetic testing and pioneering new gene therapies – promises to bring fresh hope for families affected by these diseases.   

Supporting the Manchester Eye Hospital: 

In 2014 the Manchester Royal Eye Hospital is marking its 200th anniversary.  As part of this they are seeking support to transform their paediatric ophthalmology unit.   They would like to make the clinic more family friendly and be able to give more specialist advice, information and assistance to families with children who have eye problems. 

In addition to this they would like to purchase next generation sequencers and imaging equipment.  This equipment will enable genetic testing that can speed diagnosis for patients suffering from genetic eye disease - from years to weeks.  It will also provide a vital foundation for all research undertaken by the hospital and the University into eye diseases.


For more information please visit: http://www.mreh200.org.uk/      http://www.mangen.co.uk


Press Release from Manchester Royal Eye Hospital and University of Manchester: 

Michael Owen to raise cash for eye research and treatment in Manchester

Footballer Michael Owen has announced he will run the London Marathon to support Manchester Royal Eye Hospital and scientists from The University of Manchester in their mission to find new treatments for families with genetic eye disorders.

The former England striker who played for Liverpool, Real Madrid, Newcastle United, Manchester United and Stoke City said he hoped his support would help scientists and doctors develop new treatments for patients with inherited eye disorders – where currently there is no available cure.

The University of Manchester, in partnership with the Central Manchester University Hospitals NHS Foundation Trust which runs Manchester Royal Eye Hospital, is making a major contribution to the future of genetic medicine through the Manchester Centre for Genomic Medicine.

Many of these rare genetic diseases are currently untreatable but Graeme Black, Professor of Genetics at The University of Manchester and Honorary Consultant in Genetics at St Marys Hospital Manchester together with Professor Chris Lloyd, Consultant Paediatric Ophthalmologist at Manchester Royal Eye Hospital refuse to accept this for the future. They are working hard with their colleagues to accelerate research in this area and aim to improve treatments available to patients and families affected by genetic eye diseases.  These include cataracts in young children and blindness caused by inherited diseases of the retina.

This highly specialised research aims to identify new gene variants that cause disease in the eye. It will enable doctors and researchers to better understand how such eye problems develop as well as opening up the possibility of genetic screening, better and more specific management of eye diseases and the potential for targeted therapies.

Their research has already led to improvements for patients and their families.  A new test developed for inherited eye disease has increased diagnostic pick-up rates from 15% to over 60%.

This year Manchester Royal Eye Hospital is marking the bicentenary of its foundation and hopes to raise funds to improve the children’s outpatient clinic, ensuring it is equipped with the very best diagnostic equipment for children. This equipment will not only help in diagnosis but also support research into children’s eye disease.

Professor Lloyd said:

“We are absolutely delighted to have Michael's support for the fundraising being undertaken in this the 200th year of the Manchester Royal Eye Hospital through his run in the London Marathon”.

Professor Black, who heads the Manchester Centre for Genomic Medicine, added: 

“Manchester has developed an integrated clinical and research team that represents one of the largest clinical paediatric and eye services in Europe helping us to advance developments in Genomic Medicine.

We are developing internationally-recognised gene testing protocols for diagnosis and exploring the development of new treatments for genetic disorders of the eye and improving treatments for childhood cataract. We are also improving participation in world-leading clinical trials.

We have no doubt that Michael's support will further accelerate these developments.”